FULC   $4.36  -2.68% Market Closed After Close 4.37 0.23%

Fulcrum Therapeutics Inc
Total Cash 273.78M
totalCashPerShare 4.387
EBITDA -30.88M
Total Debt 9.65M
quickRatio 21.837
currentRatio 22.072
Total Revenue 81.63M
debtToEquity 3.525
Revenue/Share 1.317
ROA -0.0689
ROE -0.07368
grossProfits
freeCashflow -6.72M
operatingCashflow -12.45M
earningsGrowth
revenueGrowth 89.909
grossMargins 0.090150006
ebitdaMargins -0.37829
operatingMargins 0.65615
profitMargins -0.24787001
enterpriseValue -56.96M
forwardPE -2.8114755
floatShares 40.45M
sharesOutstanding 62.40M
sharesShort 5.52M
sharesShortPriorMonth 11.40M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.94%
Short Ratio help_outline 3.59%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue 4.398
Price To Book help_outline 0.78
earningsQuarterlyGrowth
netIncomeToCommon -20.23M
trailingEps -0.34%
forwardEps -1.22%
enterpriseToEbitda 1.84
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.41 3Q 2024
institutionsCount 161
lastUpdated Nov. 7, 2024, 3:02 a.m.